Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What are Estimates?01:06

What are Estimates?

6.6K
It isn't easy to measure a parameter such as the mean height or the mean weight of a population. So, we draw samples from the population and calculate the mean height or mean weight of the individuals in the sample. This sample data acts as a representative measure of the population parameter. These sample statistics are known as estimates. 
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
6.6K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

828
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
828
Biostatistics: Overview01:20

Biostatistics: Overview

425
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
425
Variability: Analysis01:11

Variability: Analysis

242
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
242
Causality in Epidemiology01:21

Causality in Epidemiology

1.1K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.1K
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

338
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
338

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetics identifies obesity as a shared risk factor for co-occurring multiple long-term conditions.

Communications medicine·2026
Same author

Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models.

Statistics in medicine·2026
Same author

Getting to GRIPS with MR-Egger: Modelling directional pleiotropy independently of allele coding.

PLoS genetics·2025
Same author

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity.

Statistics in medicine·2025
Same author

Evaluating Causal Effects on Time-to-Event Outcomes in an RCT in Oncology With Treatment Discontinuation.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

Futility Analyses for the MCP-Mod Methodology Based on Longitudinal Models.

Statistics in medicine·2025

Related Experiment Video

Updated: Oct 27, 2025

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.0K

Connecting Instrumental Variable methods for causal inference to the Estimand Framework.

Jack Bowden1,2, Björn Bornkamp3, Ekkehard Glimm3,4

  • 1Exeter Diabetes Group (ExCEED), College of Medicine and Health, University of Exeter, Exeter, UK.

Statistics in Medicine
|July 21, 2021
PubMed
Summary
This summary is machine-generated.

Instrumental Variables (IV) methods offer powerful causal inference for pharmaceutical trials, addressing intercurrent events as per ICH E9 guidelines. This tutorial maps IV approaches to estimand strategies, aiding robust treatment effect estimation.

Keywords:
E9 addendumEstimand FrameworkHomogeneityIV methodsMonotonicitycausal inference

More Related Videos

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.1K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.5K

Related Experiment Videos

Last Updated: Oct 27, 2025

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.0K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.1K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.5K

Area of Science:

  • Pharmaceutical research
  • Biostatistics
  • Clinical trial methodology

Background:

  • The International Council for Harmonisation E9 guideline addendum highlights the need to address intercurrent events in clinical trials.
  • Instrumental Variables (IV) methods are established in other fields but underutilized in pharmaceutical settings for causal inference.
  • Accurate interpretation of treatment effects requires accounting for events occurring after randomization.

Purpose of the Study:

  • To provide a tutorial on Instrumental Variables (IV) methods for causal inference in pharmaceutical drug development.
  • To demonstrate how IV methods can be mapped to estimand strategies outlined in the ICH E9 addendum.
  • To facilitate the application of IV methods using standard regression models.

Main Methods:

  • Review of causal inference tools: graphical diagrams and potential outcomes.
  • Discussion of conceptual frameworks for Instrumental Variables (IV) analysis.
  • Mapping IV approaches to Treatment Policy, Principal Stratum, and Hypothetical estimand strategies.
  • Implementation details using standard regression models.
  • Examination of assumptions, testability, and sensitivity analyses for IV methods.

Main Results:

  • Detailed explanation of how IV methods align with ICH E9 estimand strategies.
  • Guidance on implementing IV analyses with standard regression techniques.
  • Discussion on the assumptions underlying IV methods and their empirical validation.
  • Application of methods to simulated data from pharmaceutical trials.

Conclusions:

  • Instrumental Variables (IV) methods provide a robust framework for causal inference in pharmaceutical trials, particularly for handling intercurrent events.
  • The tutorial clarifies the application of IV methods within the ICH E9 estimand framework, enhancing the interpretation of treatment effects.
  • This work aims to increase the adoption and understanding of IV methods in pharmaceutical research for more reliable trial outcomes.